Search research articles
Contact Us
Filters
Showing results (41-50 of 45) with videos related to
Page
of 5
Sort By:
You have reached the last page of results.
This site can display upto 45 results.
BMJ Open
|
July 1, 2021
'Give Us The Tools!': development of knowledge transfer tools to support the involvement of patient partners in the development of clinical trial protocols with patient-reported outcomes (PROs), in accordance with SPIRIT-PRO Extension
Samantha Cruz Rivera, Richard Stephens, Rebecca Mercieca-Bebber, et al.
The Lancet. Haematology
|
September 9, 2024
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial
Gordon Cook, A John Ashcroft, Ethan Senior, et al.
Gynecologic Oncology
|
October 18, 2023
Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes" [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36-45]
Stephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, et al.
BMC Medicine
|
July 5, 2023
Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study
Olga Solovyeva, Munyaradzi Dimairo, Christopher J Weir, et al.
Gynecologic Oncology
|
February 1, 2020
Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes
Stephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, et al.
Page
of 5
Search research articles
Search
Showing results (41-50 of 45) with videos related to
Sort By:
Page
of 5
You have reached the last page of results.
This site can display upto 45 results.
BMJ Open
|
July 1, 2021
'Give Us The Tools!': development of knowledge transfer tools to support the involvement of patient partners in the development of clinical trial protocols with patient-reported outcomes (PROs), in accordance with SPIRIT-PRO Extension
Samantha Cruz Rivera, Richard Stephens, Rebecca Mercieca-Bebber, et al.
The Lancet. Haematology
|
September 9, 2024
Ixazomib as consolidation and maintenance versus observation in patients with relapsed multiple myeloma eligible for salvage autologous stem-cell transplantation (Myeloma XII [ACCoRD]): interim analysis of a multicentre, open-label, randomised, phase 3 trial
Gordon Cook, A John Ashcroft, Ethan Senior, et al.
Gynecologic Oncology
|
October 18, 2023
Corrigendum to "Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes" [Gynecologic Oncology, Volume 157, Issue 1, April 2020, Pages 36-45]
Stephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, et al.
BMC Medicine
|
July 5, 2023
Development of consensus-driven SPIRIT and CONSORT extensions for early phase dose-finding trials: the DEFINE study
Olga Solovyeva, Munyaradzi Dimairo, Christopher J Weir, et al.
Gynecologic Oncology
|
February 1, 2020
Low-grade serous carcinoma (LGSC): A Canadian multicenter review of practice patterns and patient outcomes
Stephanie A Scott, Marta Llaurado Fernandez, Hannah Kim, et al.
Page
of 5